What Your Patients are Hearing

Company is giving drug users a second chance


 

An electric wire plant in Richmond, Ind., is bucking the practice of rejecting job applicants who fail drug tests.

Doug Brenneke, vice president of research and development for Belden, St. Louis

Doug Brenneke

Instead, the century-old Belden, a St. Louis-based company that also makes cable products, Internet routers, and other high-tech equipment, is offering Richmond plant applicants a job – if they complete a free 1- to 4-month drug treatment program.

The pilot program – called Pathways to Employment – aims to address two problems: the opioid crisis gripping the country and the worker shortage faced by many U.S. companies. Belden works with several local partners. The initiative was conceived with Mitchell S. Rosenthal, MD, a psychiatrist who serves as president of the Rosenthal Center for Addiction Studies and was founder of Phoenix House, the nonprofit drug treatment group. The program is thought to be the first of its kind.

“If we did the same things as we did in the past, we weren’t going to be successful in hiring the folks we needed,” said Doug Brenneke, Belden’s vice president of research and development, in an interview with National Public Radio.

Belden also is offering the program to the broader community – not just people who are part of the plant’s workforce. “We think part of the solution is offering basically a path out,” Mr. Brenneke told NPR. “It’s not a silver bullet, but it is part of an overall solution, we believe, to the epidemic.”

Click here to hear the NPR story.

Recommended Reading

Fentanyl analogs nearly double their overdose death toll
MDedge Psychiatry
For smokers, the ends may not justify the ENDS
MDedge Psychiatry
Assessing adverse events tied to outpatient opioid use in children
MDedge Psychiatry
Nearly one-quarter of presurgery patients already using opioids
MDedge Psychiatry
Opioid use disorder is a chronic condition that needs ongoing therapy
MDedge Psychiatry
How to prescribe effectively for opioid use disorder
MDedge Psychiatry
Treating substance use disorders: What do you do after withdrawal?
MDedge Psychiatry
Is marijuana a viable replacement for opioids in managing chronic non-cancer pain?
MDedge Psychiatry
Opioid use has not declined meaningfully
MDedge Psychiatry
E-cigarettes: Prices down, sales up
MDedge Psychiatry